Senju Pharmaceuticals Report issue

For profit Phase 2 Phase 3
Founded: Osaka Japan (1947)

Organization Overview

First Clinical Trial
2009
NCT00836485
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Senju Pharmaceutical Co., Ltd. | Senju USA, Inc.